Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) shares hit a new 52-week low on Monday . The stock traded as low as $241.99 and last traded at $241.99, with a volume of 110 shares. The stock had previously closed at $265.82.
Bio-Rad Laboratories Price Performance
The company has a market cap of $6.78 billion, a PE ratio of -3.72 and a beta of 0.75. The business’s 50 day moving average is $302.47 and its 200-day moving average is $322.98. The company has a debt-to-equity ratio of 0.18, a current ratio of 6.48 and a quick ratio of 4.85.
Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.90 EPS for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 71.86%.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
See Also
- Five stocks we like better than Bio-Rad Laboratories
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- The 3 Best Fintech Stocks to Buy Now
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Investing In Preferred Stock vs. Common Stock
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
